PubRank

L Xerri

Author PubWeight™ 46.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006 4.85
2 Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998 1.65
3 In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria. Antimicrob Agents Chemother 1994 1.60
4 Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia 2009 1.45
5 Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 1997 1.44
6 Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene 2006 1.15
7 T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol 2003 1.13
8 Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 2003 1.12
9 Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006 1.08
10 Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care 1996 1.05
11 Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 2002 1.05
12 Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis. J Pediatr 1983 1.00
13 Expression of gene MAGE-A4 in Reed-Sternberg cells. Blood 2000 0.96
14 A distinctive epitheliomesenchymal biphasic tumor in the duodenum: the first case of duodenoblastoma? Virchows Arch 2012 0.95
15 Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001 0.93
16 Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995 0.92
17 PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia 2005 0.90
18 Tyrosinase gene expression in human tissues. Pigment Cell Res 1993 0.89
19 Villous adenoma of the main pancreatic duct: a potentially malignant tumor? Am J Gastroenterol 1990 0.89
20 t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Leukemia 2006 0.87
21 The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells. Blood 2001 0.87
22 Experimental infections for the evaluation of beta-lactamase resistance. Antimicrob Agents Chemother 1982 0.87
23 Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor. Hybridoma 1998 0.85
24 Immunodetection in fine-needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas. Cancer 1989 0.85
25 True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms. Br J Haematol 2001 0.82
26 Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center. Ann Oncol 1998 0.82
27 The kinetics of cefuroxime in ascitic and pleural fluid. Int J Clin Pharmacol Ther Toxicol 1982 0.82
28 Depression of homograft rejection and graft-versus-host reactivity following 7,12-dimethylbenz(a)anthracene exposure in the rat. Cancer Res 1971 0.81
29 Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes. Am J Med 2001 0.81
30 Study of diffusion of cefuroxime into middle ear effusions of patients with chronic purulent otitis media. J Antimicrob Chemother 1982 0.81
31 A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma. Bone Marrow Transplant 2006 0.80
32 Unrestricted T-cell receptor V-region gene repertoire in tumor-infiltrating lymphocytes from human breast carcinomas. Cancer 1993 0.80
33 In vitro activity of cefuroxime against Treponema pallidum and Neisseria gonorrhoeae. J Antimicrob Chemother 1980 0.80
34 Study on the antibacterial activity of ceftazidime in an in vitro pharmacokinetic model. Drugs Exp Clin Res 1985 0.79
35 Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma. Histopathology 2000 0.79
36 Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. Pharmacology 1991 0.79
37 Caspases: conductors of the cell death machinery in lymphoma cells. Leuk Lymphoma 2001 0.79
38 Lymphocyte functions in the rat spleen at various times after urethan administration. Tumori 1976 0.78
39 Role of FGFs and FGF receptors in human carcinogenesis. Ann N Y Acad Sci 1991 0.78
40 Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient. Br J Haematol 2008 0.78
41 Analysis of BAX expression in human tissues using the anti-BAX, 4F11 monoclonal antibody on paraffin sections. Pathol Res Pract 1998 0.78
42 In-vitro activity of ofloxacin against Chlamydia trachomatis. J Chemother 1989 0.77
43 In vitro activity of cefuroxime against Treponema pallidum. J Antimicrob Chemother 1978 0.76
44 Reduced number of Langerhans cells in oesophageal mucosa from AIDS patients. Histopathology 1999 0.76
45 Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 1987 0.75
46 Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions. Mol Pathol 2001 0.75
47 Low-grade rectal malt lymphoma occurring in a patient with chronic lymphocytic leukaemia. Br J Haematol 2002 0.75
48 Type IV collagen immunostaining and computerized image analysis (SAMBA) in breast and endometrial disorders. Histopathology 1989 0.75
49 Pharmacokinetic studies of cefuroxime in patients with liver cirrhosis. Arzneimittelforschung 1982 0.75
50 [Tools of molecular biology. Diagnostic use of DNA arrays]. Ann Pathol 2000 0.75
51 [Splenic rupture revealing Waldenström disease]. Presse Med 1998 0.75
52 Absence of ceftazidime activity against experimental syphilis. J Antimicrob Chemother 1989 0.75
53 [Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution]. Ann Pathol 1997 0.75
54 [The tenant has a headache]. Rev Med Interne 2004 0.75
55 Immunocytochemical assays in human endometrial carcinomas: a multiparametric computerized analysis and comparison with nonmalignant changes. Gynecol Oncol 1989 0.75
56 Multicystic peritoneal mesothelioma: report of three cases. Pathologica 2008 0.75
57 Leukopenia, thrombocytopenia, and acute autoimmune hemolytic anemia associated with an unusual (type 2/4) Hodgkin's disease: case report. Am J Hematol 1996 0.75
58 Image analysis for histochemical study of glucose-6-phosphatase inactivation by diethyl pyrocarbonate in normal human liver. J Histochem Cytochem 1990 0.75
59 [Lymphoproliferative syndrome induced by Epstein-Barr virus after kidney transplantation: value of genotypic analysis]. Presse Med 1995 0.75
60 Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia. Leuk Lymphoma 2001 0.75
61 Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients. Leukemia 1999 0.75
62 Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center. Bone Marrow Transplant 2000 0.75
63 [Castleman's disease located in the central nervous system]. Rev Neurol (Paris) 2003 0.75
64 [Giant leiomyoma of the inferior vena cava]. Ann Pathol 1989 0.75
65 Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid. Farmaco 1996 0.75
66 [Cefuroxime. Pharmacokinetic aspects in man after intravenous administration under different conditions]. G Ital Chemioter 1981 0.75
67 [An ulcerative tumor of the fundic mucosa. What is your diagnosis? Diagnosis: Gastric plasma cell granuloma]. Ann Pathol 2000 0.75
68 [A typical case...]. Rev Med Interne 2005 0.75
69 [Pulmonary aspergillomas and pancreatic localization in disseminated aspergillosis]. Presse Med 1988 0.75
70 [Cefuroxime: placental passage and concentrations in the uterus and adnexa uteri. Preliminary results]. Ann Ostet Ginecol Med Perinat 1981 0.75
71 [Cefuroxime, a new antibiotic. Action in vitro and in vivo]. G Ital Chemioter 1978 0.75
72 In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses. Chemioterapia 1984 0.75
73 [Multicentric bone chloroma disclosed by pleural cytology]. Arch Anat Cytol Pathol 1990 0.75
74 Ofloxacin: therapeutic activity in experimental infections. Chemioterapia 1986 0.75
75 [Ultrastructural study of the liver in Niemann-Pick disease type C]. Ann Pathol 1989 0.75
76 Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis. Int J Clin Pharmacol Ther Toxicol 1982 0.75
77 Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model. Chemioterapia 1986 0.75
78 Cefuroxime concentrations in pericardial fluid. J Antimicrob Chemother 1981 0.75
79 [Determination in time of the residual antibacterial activity after disinfection of hands with Citrosil products with benzalkonium chloride base]. Minerva Chir 1988 0.75
80 [Hepatic MALT lymphoma disclosing a nodal extension]. Ann Pathol 2000 0.75
81 [Use of high-density filters ("DNA arrays") for gene expression analysis in human tissues]. Ann Pathol 1999 0.75
82 Correlation between laminin and type IV collagen distribution in breast carcinomas, and estrogen receptors expression, lymph node and vascular involvement. Med Oncol Tumor Pharmacother 1990 0.75
83 [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy]. Clin Ter 1991 0.75
84 Cytomegalovirus retinitis revealing a leukemic gamma/delta T-cell lymphoma. Haematologica 1999 0.75
85 Ofloxacin: in vitro and in vivo activity. Chemioterapia 1987 0.75
86 [Cefuroxim. Importance of beta-lactamase resistance, evaluated in vitro and in vivo]. G Ital Chemioter 1981 0.75